Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $1.22 Million - $1.59 Million
150,000 Added 96.53%
305,400 $3.19 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $759,968 - $1.09 Million
-101,600 Reduced 39.53%
155,400 $1.59 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $758,880 - $998,138
105,400 Added 69.53%
257,000 $1.94 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $13,376 - $18,192
1,600 Added 1.07%
151,600 $1.34 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $751,275 - $895,860
-94,500 Reduced 38.65%
150,000 $1.37 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $881,066 - $1.13 Million
-120,200 Reduced 32.96%
244,500 $2.3 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $359,450 - $463,645
-45,500 Reduced 11.09%
364,700 $2.92 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $1.03 Million - $1.25 Million
122,700 Added 42.68%
410,200 $4 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $945,450 - $1.1 Million
95,500 Added 49.74%
287,500 $2.85 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $1.68 Million - $2.08 Million
162,000 Added 540.0%
192,000 $2.22 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $344,400 - $441,599
-40,000 Reduced 57.14%
30,000 $290,000
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $257,100 - $380,700
30,000 Added 75.0%
70,000 $631,000
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $811,999 - $1.57 Million
-100,000 Reduced 71.43%
40,000 $369,000
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $1.05 Million - $1.28 Million
-50,000 Reduced 26.32%
140,000 $3.02 Million
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $2 Million - $2.65 Million
-120,000 Reduced 38.71%
190,000 $3.25 Million
Q4 2017

Feb 13, 2018

BUY
$11.23 - $19.1 $224,600 - $382,000
20,000 Added 6.9%
310,000 $5.88 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $4.47 Million - $9.33 Million
290,000
290,000 $5.1 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Continental Advisors LLC Portfolio

Follow Continental Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.